abstract |
The present invention relates to tumor-specific anti-EGFR antibodies and their applications. The present invention specifically provides an antibody that recognizes EGFRvIII or overexpressed EGFR in tumor cells but hardly recognizes EGFR in normal cells. This can be applied to the manufacture of drugs for diagnosing various antitumor drugs and tumors have. |